Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter ended June 30, 2013.
Exact reported total revenues of $1.0 million for the second quarter of 2013, compared to total revenues of $1.0 million during the same period of 2012. Total revenues for the six-month period ended June 30, 2013, were $2.1 million, compared to $2.1 million during the first six months of 2012.
Help employers find you! Check out all the jobs and post your resume.
Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter ended June 30, 2013.
Exact reported total revenues of $1.0 million for the second quarter of 2013, compared to total revenues of $1.0 million during the same period of 2012. Total revenues for the six-month period ended June 30, 2013, were $2.1 million, compared to $2.1 million during the first six months of 2012.
Help employers find you! Check out all the jobs and post your resume.
